Jasper Therapeutics enters $100M ATM equity offering with Jefferies; terminates prior Cantor agreement

Jasper Therapeutics, Inc.

Company entered Open Market Sale Agreement with Jefferies LLC to sell up to $100M of common stock.
Jefferies will receive 3.0% commission on gross sales price per share; issuer has no obligation to sell.
Prior ATM agreement with Cantor Fitzgerald terminated effective March 14, 2025; no shares sold under it.
Offering will be made under new S-3 registration statement filed March 19, 2025.
No material penalties incurred from termination of Cantor agreement.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-025123
form_type: 8-K
ticker: JSPR
cik: 0001788028
company_name: Jasper Therapeutics, Inc.
filed_at: 2025-03-19T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.869989+00:00
generated_at: 2026-05-24T12:00:18.396426+00:00
sec_items: ["1.01", "1.02", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-025123
json_url: https://secwatch.observer/filing/0001213900-25-025123.json
markdown_url: https://secwatch.observer/filing/0001213900-25-025123.md
text_url: https://secwatch.observer/filing/0001213900-25-025123.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/0001213900-25-025123-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1788028/000121390025025123/ea0234885-8k_jasper.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Barings BDC receives $67M cash from adviser, enters new $11M credit support for Sierra legacy investments

Barings BDC, Inc. June 1, 2026, 4:15 PM ET other_material Items 1.01, 1.02, 9.01

same SEC item: 1.01, 1.02, 9.01 same event type: other_material similar materiality

zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred

zSpace, Inc. June 1, 2026, 8:00 AM ET other_material Items 1.01, 1.02, 2.03, 3.02, 5.03, 9.01

same SEC item: 1.01, 1.02, 9.01 same event type: other_material similar materiality

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01